The company proposes to incorporate a wholly-owned subsidiary company named "Bacil Research & Development Private Limited". The proposed subsidiary is intended to be a private limited company and will be wholly-owned by Bacil Pharma Limited.
The stated objective for incorporating this new entity is to undertake research and development activities, along with other allied activities permitted under applicable laws.
The incorporation is not yet finalized and is subject to receiving approval from the Registrar of Companies (ROC) and other applicable statutory authorities.
The intimation was digitally signed by Mrs. Chaitali Kalpataru Shah, Director & CFO of Bacil Pharma Limited (DIN: 11167778), on 18th June 2026 at 14:44:46 IST.
#BacilPharma #SEBIRegulation30 #SubsidiaryIncorporation #R&D #RegulatoryCompliance #Neutral